LYTIX BIOPHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.7 NOK | +4.69% |
|
+11.67% | +37.86% |
| 30/05 | Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024 | |
| 30/05 | Lytix Biopharma AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LYTIX BIOPHARMA | Other Biotechnology & Medical Research | +4.69% | +11.67% | +37.86% | -27.57% | - | 3.02Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LYTIX Stock
- Charts Lytix Biopharma
- Comparison Chart
